Back to Journals » Drug Design, Development and Therapy » Volume 19
Dexmedetomidine Attenuated Neuron Death, Cognitive Decline, and Anxiety-Like Behavior by Inhibiting CXCL2 in CA1 Region of AD Mice [Corrigendum]
Ma K, An C, Li M, et al. Drug Des Devel Ther. 2024;18:5351—5365.
The authors have advised due to an error that occurred inadvertently at the time of figure assembly, Figure 2 on page is incorrect. The trajectory map for the control group in Figure 2F is a duplication of the trajectory map in Figure 4E (AD+Dex group).
The correct Figure 2 is as follows.
Figure 2 Continued.
The authors apologize for this error and advise it does not affect the results and conclusions of the paper.
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.